Autologous Dendritic Cell-Tumor Cell Immunotherapy for Metastatic Melanoma
Clinical trial NCT01875653 · TERMINATED
Trial details
- NCT number
- NCT01875653
- Sponsor
- Lisata Therapeutics, Inc.
- Status
- TERMINATED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2014-10-01
- Primary completion
- 2016-01-01
- Enrollment
- 4
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.